<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A co-operative study was conducted to determine the clinical characteristics of patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> who were diagnosed and treated at neurosurgical institutes in Korea before 1995 </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-six hospitals contributed 505 cases and among them, the clinical characteristics of 334 patients with definite <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> were evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>The number of patients began to increase from the late 1980s, and after that approximately 20 patients were treated each year </plain></SENT>
<SENT sid="3" pm="."><plain>There were two age peaks: from six to 15 and from 31 to 40 years of age </plain></SENT>
<SENT sid="4" pm="."><plain>Haemorrhagic manifestations occurred in approximately 43% of the patients </plain></SENT>
<SENT sid="5" pm="."><plain>The major clinical manifestations were haemorrhage in adults (62.4%) and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in children (61.2%) </plain></SENT>
<SENT sid="6" pm="."><plain>Overall 54.5% of the patients experienced decreased consciousness levels, mainly due to intracranial haemorrhage or <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In the patients with ischemic manifestations, the adult patients were more likely to have <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> than the pediatric patients (80% vs. 39%) and the pediatric patients were more likely to have <z:hpo ids='HP_0002326'>TIA</z:hpo> (61% vs. 25%) </plain></SENT>
<SENT sid="8" pm="."><plain>Thirty eight percent of the patients underwent bypass surgery and 53% of these procedures were performed bilaterally </plain></SENT>
<SENT sid="9" pm="."><plain>Treatment policies, including indications for bypass surgery and commonly used drugs, were somewhat different according to the institution </plain></SENT>
<SENT sid="10" pm="."><plain>Overall favorable outcome was 73%, and the most significant factor affecting poor outcome was haemorrhagic manifestation </plain></SENT>
<SENT sid="11" pm="."><plain>This article describes the characteristics of 334 patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e>, who were diagnosed and treated at neurosurgical institutes in Korea before 1995 </plain></SENT>
</text></document>